Clinical Trial Update: Treatment of Advanced Renal Cell Carcinoma With Quinacrine [Phase 2]

View source ↗

Summary

A Phase 2 trial of quinacrine for advanced renal cell carcinoma has been withdrawn, per the study update from Cleveland BioLabs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Quinacrine (quinacrine)

Snippet

Sponsor: Cleveland BioLabs | Conditions: Renal Cell Carcinoma | Phase 2 | Status: WITHDRAWN